RT Journal Article
SR Electronic
T1 Quantification of SARS-CoV-2 and cross-assembly phage (crAssphage) from wastewater to monitor coronavirus transmission within communities
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.21.20109181
DO 10.1101/2020.05.21.20109181
A1 Green, Hyatt
A1 Wilder, Maxwell
A1 Collins, Mary
A1 Fenty, Ariana
A1 Gentile, Karen
A1 Kmush, Brittany L.
A1 Zeng, Teng
A1 Middleton, Frank A.
A1 Larsen, David A.
YR 2020
UL http://medrxiv.org/content/early/2020/05/23/2020.05.21.20109181.abstract
AB Wastewater surveillance of SARS-CoV-2 has become an attractive tool for combating the spread of COVID-19 by assessing the presence or levels of the virus shed in a population. However, the methods to quantify viral RNA and to link those quantities to the level of infection within the community vary. In this study, we sought to identify and optimize scalable methods for recovery of viral nucleic acids from wastewater and attempted to use a constitutive member of the gut virome, human-specific crAssphage, to help account for unknown levels of SARS-CoV-2 decay and dilution in the wastewater infrastructure. Results suggest that ultracentrifugation of a small volume of wastewater through a 50% sucrose cushion followed by total nucleic acid extraction yielded quantifiable virus in an area with a modest number of COVID-19 cases. Further, the ratio of log10(SARS-CoV-2):log10(crAssphage) appears to be associated with the cumulative incidence of COVID-19 in the Syracuse, NY area. In areas where ultracentrifuges are available, these methods may be used to link SARS-CoV-2 quantities in wastewater to levels of transmission within communities with sewer service.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work would not have been possible with seed funding from Syracuse University, the Environmental Data Science Initiative at SUNY-ESF, and the SUNY Discovery Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Public health surveillance of wastewater is exempt from IRB requirements.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are in the process of being made publicly available.